some interesting reading...XKEM picked again:
1. A Due Diligence Site
Hombre Munchkin| 06-10-06 | 01:38 PM
Greetings To All:
The Munchkin Man is pleased to announce that he has upgraded XeChem International Inc (XKEM.OB) to his list of his top 5 penny stocks to buy and hold for the long term.
XKEM.OB was also one of the Munchkin Man's Penny Stock Picks Of The Week Of June 05, 2006. This stock distinguished itself with an end-of-the-week (EOD) percent gain of +81.25%
In the Munchkin Man's original post to this thread, shown directly above, which was posted before the markets opened on the date of June 06, 2006, the Munchkin Man posted a link to the company website and its latest press release, also dated before the opening of the markets, on the date of June 06, 2006.
The Munchkin Man has just discovered a web site which is dedicated to the compilation of due diligence on this company and its stock.
Here is a link to this site:
A DUE DILIGENCE SITE ON XECHEM INTERNATIONAL INC
In spite of the rather "pumpish" phrase at the very top of the heading "Stock Pick Of The Century", this is not a "pump" site.
Instead, this is a site created by investors of XKEM, and this is the only stock they have ever profiled.
The Munchkin Man will also quote the notice and disclaimer on the main page of this site:
_____________________
"PennyPickers.com was created by a group of investors who are heavily invested in Xechem International. Significant due diligence is put into our pick by a small group of dedicated investors. This site is a compilation of extensive research into our investment, and is here to help others. Before making any decision to buy or sell any stock mentioned on this site, you MUST do your own due diligence! Do not buy or sell based on our interest in this stock!"
______________________
The Munchkin Man will leave it to you to read the summary information about this company and its stock on the front page of this site.
The closing price on this stock on the date of Friday,
June 09, 2006, was $0.029 a share.
Due to its +81.25% end-of-the-week (EOD) gain last week, the Munchkin Man would not be surprised if there is a bit of a sell-off this coming Monday, June 12, 2006.
On the other hand, this stock closed out at the exact same price of $0.029 on the date of Thursday, June 11, 2006. A lot of investors like to cash out their profit making stocks on Friday, and here is one which held its ground at the $0.029 yard line.
The Munchkin Man shall now provide you with a link to a message board which contains some excellent due diligence on this stock:
A MESSAGE BOARD FOR XKEM
For the record, the Munchkin Man does not post of this site. At least, not yet. This is because the Munchkin Man has only just recently discovered it.
The Munchkin Man is herewith designating this as the first official conversation thread dedicated to XeChem International Inc (XKEM.OB).
The Munchkin Man will be providing regular updates on this stock on this thread. If any of you happen to develop an interest in this stock, the Munchkin Man warmly invites your participation as well.
The Munchkin Man shall close for now.
Good luck to all.
Best Wishes,
Munchkin Man
2. XKEM'S Lead Researcher Wins Award!
Hombre Munchkin| 06-15-06 | 07:48 AM
Greetings To All:
The Munchkin Man is pleased to report that Dr. Donald J. Abraham, Ph.D., professor and department chair of medicinal chemistry and director of the Institute for Structural Biology and Drug Discovery at Virginia Commonwealth University, was once selected by the AACP Board of Directors as the recipient of the 2002 AACP Paul Dawson Biotechnology Award.
You can read more about this from the article linked below:
ON DR. DONALD ABRAHAM
Due to the Munchkin Man's powers of telephathy, the Munckin Man can hear two questions already, coming in from somebody who will read this post, in the very new future:
__________________
***So what? That's old news.
The Munchkin Man's reply:
The Munchkin Man has another term for "old news."
It's called history.
Are you bashing history?
___________________
***So what's that got to do with this stock you're pumping?"
First of all, the Munchkin Man does not "pump" stocks.
The Munchkin Man promotes them.
The Munchkin Man points out and spreads the good word of their positives.
In order to answer your question, the Munchkin Man will refer you to the article linked below:
DR. ABRAHAM'S RESEARCH
This article is a little more current -- date on June 06, 2006.
Dr. Abraham happens to be the lead resercher of Xechem International Inc.
Why all the excitement over this company and its stock?
Read this:
_____
"As previously reported by Xechem International, Xechem Nigeria has submitted its Drug Master File (DMF) dossier with Nigeria's drug regulatory agency, the National Agency for Food and Drug Administration and Control (NAFDAC), seeking full registration for NICOSAN(TM). It is currently awaiting final word from that agency on its submission. Subject to the necessary approvals, Xechem has indicated that it would like to launch the drug in Nigeria by early July 2006, and shortly thereafter to embark on the clinical trials in the US hospitals for FDA approval through the Investigational New Drug (IND) Application for sale of the drug in the United States.
_____
Quoted from the following due diligence site:
A DUE DILIGENCE SITE FOR XECHEM INTERNATIONAL INC
This stock closed out on Wednesday, June 14, 2006, at a price of $0.0283 a share. The Munchkin Man believes that this type of price will not be hanging around too much longer.
Remember -- you heard it from the Munchkin Man on this forum. If you buy this stock, you can thank him later.
Good luck to all.
Best Wishes,
Munchkin Man
3. What Are Orphan Drugs?
Hombre Munchkin| 06-18-06 | 09:28 AM
Greetings To All:
As an introduction to the post, the Munchkin Man would like to refer you once again to the following press release:
XECHEM RECEIVES ORPHAN DRUG DESIGNATION FROM THE FDA FOR ITS ANTI-SICKLING DRUG 5-HMF
Upon reading the title to this press release, many people ask the question:
"What is an orphan drug."
Even the Munchkin Man asked this question when he first saw this press release.
Here is a web site page, straight from the U.S. Food And Drug Admistration website, which will tell you all about orphan drugs:
ORPHAN DRUG FAQS
The Munchkin Man found the following excerpt to be especially compelling:
______________________________
"Are orphan products approved faster than other drugs?
Historically, the approval time for orphan products as a group has been considerably shorter than the approval time for other drugs.
This reduced approval time is often due to the fact that many orphan products receive expedited review or accelerated approval because they are for serious or life-threatening disease."
_______________________________
It is a well known fact that FDA approval for any drug can be a very long wait. Based upon the above, the orphan drug status of this drug appears to bode well for the expedition of ultimate FDA approval.
The Munchkin Man advises you to perform your own research and due diligence if and before you decide to buy this stock.
The best source of due diligence on this company and this stock can be found in the link shown below:
ALL ABOUT XECHEM INTERNATIONAL INC
For the purpose of personal disclosure, the Munchkin Man does hold a position in this stock and intends to maintain this position for a long-term hold.
Good luck to all.
Best Wishes,
Munchkin Man
AI
News 
Market Data 
Discover 
